Joan Heminway

Faculty Forum, January 2016
January 21, 2016 11:36 am
Faculty Forum is a monthly feature highlighting the achievements of faculty at UT Law including publications in academia and the media, speaking engagements, interviews, awards, and other accomplishments.
Faculty Forum (Blaze and Baxter)

Faculty Forum, November 2015
November 17, 2015 1:53 pm
Faculty Forum is a monthly feature highlighting the achievements of faculty at UT Law including publications in academia and the media, speaking engagements, interviews, awards, and other accomplishments.

Faculty Forum, September 2015
September 21, 2015 8:00 am
Faculty Forum is a monthly feature highlighting the achievements of faculty at UT Law including publications in academia and the media, speaking engagements, interviews, awards, and other accomplishments.

In the news: Heminway weighs in on EPB ownership case
August 25, 2015 11:01 am
Joan Heminway, the W.P. Toms Distinguished Professor of Law at the University of Tennessee College of Law, recently spoke to the Chattanooga Times Free Press regarding a case that will determine whether local energy provider Electric Power Board (EPB) is a branch of City Hall in Chattanooga or its own corporate identity.
Faculty Forum (Blaze and Baxter)

Faculty Forum, August 2015
August 21, 2015 2:49 pm
Faculty Forum is a monthly feature highlighting the achievements of faculty at UT Law including publications in academia and the media, speaking engagements, interviews, awards, and other accomplishments.

In the news: Heminway discusses crowdfunding history
July 22, 2015 10:35 am
Joan Heminway, the W.P. Toms Distinguished Professor of Law at the University of Tennessee College of Law, recently spoke to The Real Deal, New York City’s most prominent real estate magazine, about legislative reform that has affected crowdfunding in the past few years.

In the news: Heminway discusses Mylan land deal
July 13, 2015 10:57 am
Joan Heminway, the W.P. Toms Distinguished Professor of Law at the University of Tennessee College of Law, recently spoke to the Pittsburgh Tribune-Review for their story on Mylan N.V., a global generic and specialty pharmaceuticals company.